Heil, M. L., Decker, J. M., Sfakianos, J. N., Shaw, G. M., Hunter, E., & Derdeyn, C. A. (2004). Determinants of Human Immunodeficiency Virus Type 1 Baseline Susceptibility to the Fusion Inhibitors Enfuvirtide and T-649 Reside outside the Peptide Interaction Site. American Society for Microbiology.

Heil, Marintha L., Julie M. Decker, Jeffrey N. Sfakianos, George M. Shaw, Eric Hunter, and Cynthia A. Derdeyn. Determinants of Human Immunodeficiency Virus Type 1 Baseline Susceptibility to the Fusion Inhibitors Enfuvirtide and T-649 Reside Outside the Peptide Interaction Site. American Society for Microbiology, 2004.

Heil, Marintha L., et al. Determinants of Human Immunodeficiency Virus Type 1 Baseline Susceptibility to the Fusion Inhibitors Enfuvirtide and T-649 Reside Outside the Peptide Interaction Site. American Society for Microbiology, 2004.